207 related articles for article (PubMed ID: 24890200)
1. Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation.
Challis BG; Harris J; Sleigh A; Isaac I; Orme SM; Seevaratnam N; Dhatariya K; Simpson HL; Semple RK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):855-61. PubMed ID: 24890200
[TBL] [Abstract][Full Text] [Related]
2. Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks.
Christesen HB; Brusgaard K; Beck Nielsen H; Brock Jacobsen B
Clin Endocrinol (Oxf); 2008 May; 68(5):747-55. PubMed ID: 18208578
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in phenotype of hyperinsulinism caused by activating glucokinase mutations: a novel mutation and its functional characterization.
Martínez R; Gutierrez-Nogués Á; Fernández-Ramos C; Velayos T; Vela A; ; Navas MÁ; Castaño L
Clin Endocrinol (Oxf); 2017 Jun; 86(6):778-783. PubMed ID: 28247534
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.
Wabitsch M; Lahr G; Van de Bunt M; Marchant C; Lindner M; von Puttkamer J; Fenneberg A; Debatin KM; Klein R; Ellard S; Clark A; Gloyn AL
Diabet Med; 2007 Dec; 24(12):1393-9. PubMed ID: 17976205
[TBL] [Abstract][Full Text] [Related]
5. Glucokinase activating mutation causing hypoglycaemia diagnosed late in adult who fasts for Ramadhan.
Loh WJ; Dacay LM; Tan CSH; Ang SF; Yap F; Lim SC; Khoo J
Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34184638
[TBL] [Abstract][Full Text] [Related]
6. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
7. Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene.
Barbetti F; Cobo-Vuilleumier N; Dionisi-Vici C; Toni S; Ciampalini P; Massa O; Rodriguez-Bada P; Colombo C; Lenzi L; Garcia-Gimeno MA; Bermudez-Silva FJ; Rodriguez de Fonseca F; Banin P; Aledo JC; Baixeras E; Sanz P; Cuesta-Muñoz AL
Mol Endocrinol; 2009 Dec; 23(12):1983-9. PubMed ID: 19884385
[TBL] [Abstract][Full Text] [Related]
8. TWO OPPOSITE PHENOTYPES OF GLUCOSE DISORDERS IN A FAMILY WITH HETEROZYGOUS P.SER453LEU (C.1358C> T) MUTATION IN THE GLUCOKINASE (GCK) GENE: MATURITY ONSET DIABETES IN YOUNG AND INSULINOMA.
Demiral M; Çelebi HBG; Cander S; Yerci O; Eren E; Demirbilek H
Acta Endocrinol (Buchar); 2022; 18(4):458-465. PubMed ID: 37152879
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations.
Li C; Juliana CA; Yuan Y; Li M; Lu M; Chen P; Boodhansingh KE; Doliba NM; Bhatti TR; Adzick NS; Stanley CA; De León DD
Diabetes; 2023 Dec; 72(12):1809-1819. PubMed ID: 37725835
[TBL] [Abstract][Full Text] [Related]
10. Impact of Type 2 diabetes on Glucokinase diabetes (GCK-MODY) phenotype in a Roma (Gypsy) family - case report.
Stanik J; Kusekova M; Huckova M; Valentinova L; Masindova I; Stanikova D; Ferenczova J; Gasperikova D; Klimes I
Endocr Regul; 2012 Apr; 46(2):99-105. PubMed ID: 22540858
[TBL] [Abstract][Full Text] [Related]
11. Phenotype variability and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene.
Borowiec M; Mysliwiec M; Fendler W; Antosik K; Brandt A; Malecki M; Mlynarski W
Acta Diabetol; 2011 Sep; 48(3):203-8. PubMed ID: 21437567
[TBL] [Abstract][Full Text] [Related]
12. Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans.
Peter A; Stefan N; Cegan A; Walenta M; Wagner S; Königsrainer A; Königsrainer I; Machicao F; Schick F; Häring HU; Schleicher E
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1126-30. PubMed ID: 21490074
[TBL] [Abstract][Full Text] [Related]
13. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.
Cuesta-Muñoz AL; Huopio H; Otonkoski T; Gomez-Zumaquero JM; Näntö-Salonen K; Rahier J; López-Enriquez S; García-Gimeno MA; Sanz P; Soriguer FC; Laakso M
Diabetes; 2004 Aug; 53(8):2164-8. PubMed ID: 15277402
[TBL] [Abstract][Full Text] [Related]
14. Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg).
Gilis-Januszewska A; Bogusławska A; Kowalik A; Rzepka E; Soczówka K; Przybylik-Mazurek E; Głowa B; Hubalewska-Dydejczyk A
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680961
[TBL] [Abstract][Full Text] [Related]
15. Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
Christesen HB; Tribble ND; Molven A; Siddiqui J; Sandal T; Brusgaard K; Ellard S; Njølstad PR; Alm J; Brock Jacobsen B; Hussain K; Gloyn AL
Eur J Endocrinol; 2008 Jul; 159(1):27-34. PubMed ID: 18450771
[TBL] [Abstract][Full Text] [Related]
16. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
[TBL] [Abstract][Full Text] [Related]
17. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
[TBL] [Abstract][Full Text] [Related]
18. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Gloyn AL
Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
[TBL] [Abstract][Full Text] [Related]
19. The novel GCK variant p.Val455Leu associated with hyperinsulinism is susceptible to allosteric activation and is conducive to weight gain and the development of diabetes.
Langer S; Waterstradt R; Hillebrand G; Santer R; Baltrusch S
Diabetologia; 2021 Dec; 64(12):2687-2700. PubMed ID: 34532767
[TBL] [Abstract][Full Text] [Related]
20. [A three-year follow-up observation of a pedigree of maturity onset diabetes of the young caused by a novel mutation of glucokinase and literature review].
Ma ML; Ping F; Chang YS; Li YX
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):366-371. PubMed ID: 32370465
[No Abstract] [Full Text] [Related]
[Next] [New Search]
